These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22906823)

  • 1. Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study.
    Roseman M; Turner EH; Lexchin J; Coyne JC; Bero LA; Thombs BD
    BMJ; 2012 Aug; 345():e5155. PubMed ID: 22906823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
    Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD
    BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
    JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reporting of financial and non-financial conflicts of interest by authors of systematic reviews: a methodological survey.
    Hakoum MB; Anouti S; Al-Gibbawi M; Abou-Jaoude EA; Hasbani DJ; Lopes LC; Agarwal A; Guyatt G; Akl EA
    BMJ Open; 2016 Aug; 6(8):e011997. PubMed ID: 27515760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A structured approach to information retrieval improved identification of funding and researchers' conflicts of interest in trials included in Cochrane reviews.
    Faltinsen E; Todorovac A; Boutron I; Stewart LA; Hróbjartsson A; Lundh A
    J Clin Epidemiol; 2023 Sep; 161():104-115. PubMed ID: 37399968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009.
    Benea C; Turner KA; Roseman M; Bero LA; Lexchin J; Turner EH; Thombs BD
    Syst Rev; 2020 Apr; 9(1):77. PubMed ID: 32268911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reporting of Financial and Non-financial Conflicts of Interest in Systematic Reviews on Health Policy and Systems Research: A Cross Sectional Survey.
    Bou-Karroum L; Hakoum MB; Hammoud MZ; Khamis AM; Al-Gibbawi M; Badour S; Justina Hasbani D; Cruz Lopes L; El-Rayess HM; El-Jardali F; Guyatt G; Akl EA
    Int J Health Policy Manag; 2018 Aug; 7(8):711-717. PubMed ID: 30078291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between authorship contributions and authors' industry financial ties among oncology clinical trials.
    Rose SL; Krzyzanowska MK; Joffe S
    J Clin Oncol; 2010 Mar; 28(8):1316-21. PubMed ID: 20065190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Authors of clinical trials seldom reported details when declaring their individual and institutional financial conflicts of interest: a cross-sectional survey.
    Hakoum MB; Noureldine H; Habib JR; Abou-Jaoude EA; Raslan R; Jouni N; Hasbani DJ; Lopes LC; Guyatt G; Akl EA
    J Clin Epidemiol; 2020 Nov; 127():49-58. PubMed ID: 32512186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conflicts of Interest Among Authors of Systematic Reviews and Meta-analyses Investigating Interventions for Melanoma: Cross-sectional Literature Study.
    Rulon Z; Powers K; Anderson JM; Weaver M; Johnson A; Hartwell M; Vassar M
    JMIR Dermatol; 2021 Jun; 4(1):e25858. PubMed ID: 37632810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial registry use in anaesthesiology systematic reviews: A cross-sectional study of systematic reviews published in anaesthesiology journals and the Cochrane Library.
    Umberham BA; Detweiler BN; Sims MT; Vassar M
    Eur J Anaesthesiol; 2017 Dec; 34(12):797-807. PubMed ID: 28731924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary outcome switching among drug trials with and without principal investigator financial ties to industry: a cross-sectional study.
    Jones CW; Misemer BS; Platts-Mills TF; Ahn R; Woodbridge A; Abraham A; Saba S; Korenstein D; Madden E; Keyhani S
    BMJ Open; 2018 Feb; 8(2):e019831. PubMed ID: 29439079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do Author Conflicts of Interest and Industry Sponsorship Influence Outcomes of Systematic Reviews and Meta-Analyses Regarding Glaucoma Interventions? A Cross-sectional Analysis.
    Wise A; Mannem D; Anderson JM; Weaver M; Hartwell M; Vassar M
    J Glaucoma; 2021 Apr; 30(4):293-299. PubMed ID: 33769356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying competing interest disclosures in systematic reviews of surgical interventions and devices: a cross-sectional survey.
    Yu J; Su G; Hirst A; Yang Z; Zhang Y; Li Y
    BMC Med Res Methodol; 2020 Oct; 20(1):260. PubMed ID: 33076823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Conflicts of Interest and Authors' Positions on Harms of Varenicline: a Cross-Sectional Analysis.
    Fabbri A; Nejstgaard CH; Grundy Q; Bero L; Dunn AG; Mohammad A; Mintzes B
    J Gen Intern Med; 2022 Feb; 37(2):290-297. PubMed ID: 34037923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review.
    Nejstgaard CH; Bero L; Hróbjartsson A; Jørgensen AW; Jørgensen KJ; Le M; Lundh A
    BMJ; 2020 Dec; 371():m4234. PubMed ID: 33298430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting of adverse events, conflict of interest and funding in randomised controlled trials of antibiotics: a secondary analysis.
    Bakhit M; Jones M; Baker J; Nair R; Yan K; Del Mar C; Scott AM
    BMJ Open; 2021 Jul; 11(7):e045406. PubMed ID: 34285004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome reporting among drug trials registered in ClinicalTrials.gov.
    Bourgeois FT; Murthy S; Mandl KD
    Ann Intern Med; 2010 Aug; 153(3):158-66. PubMed ID: 20679560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to conflicts of interest policy in Cochrane reviews where authors are also editorial board members: A cross-sectional analysis.
    Pacheco RL; Latorraca COC; Martimbianco ALC; Miranda E; Fontes LES; Nunan D; Riera R
    Res Synth Methods; 2022 Jan; 13(1):6-11. PubMed ID: 34165922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.